3-(2,6-Dimethylmorpholino)-5-fluoroaniline hydrochloride, 5g

ethyl 1-tert-butyl-5-chloropyrazole-4-carboxylate, 97%, 250mg

4-Chloro-1H-pyrrolo[2,3-b]pyridin-6-amine, 95.0%, 250mg

2-methyl-5,6-dihydro-1,4-oxathiine-3-carboxylic acid, 95.0%, 250mg

PMPip BTA, 100 g, >=99%, glass packaging

4-Bromo-1H,2H,3H-pyrrolo[2,3-c]pyridine, 98%, 1g

N-Methyl-1H-pyrazol-3-amine, 95.0%, 5g

2-Cyclohexylpropan-2-amine hydrochloride, 98%, 250mg

Benzenesulfonamide, 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]-, 98%, 50mg

4-Pyridylacetic acid hydrochloride, 95.0%, 500g

1-(4-methyl-1,3-thiazol-2-yl)methanamine, 95.0%, 250mg

3-Bromo-1h-indol-5-amine, 98+%, 5g

1-[2-(2-aminoethoxy)ethoxy]-2-(2-azidoethoxy)ethane, 95.0%, 1g